Article
Ruxolitinib inhibits transforming JAK2 fusion proteins in vitro and induces complete cytogenetic remission in t(8;9)(p22;p24)/PCM1-JAK2–positive chronic eosinophilic leukemia
16 Aug 2012
Abstract excerpt
status: Published
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.